Filter Results

PharmacoKinetic Assays
Per Page

Pharmacokinetics (PK) is the study of how a drug is absorbed, distributed, metabolized, and excreted over time. Understanding the pharmacokinetic and pharmacodynamic behavior of a given therapeutic drug is an essential element of understanding its effectiveness and safety, as well as identifying the proper dosage and distribution. PK assay bioanalytical testing methods are used to determine concentration time profiles of the drug and metabolites in biological sample fluids, providing information necessary for PK analysis. PK assays are a vital component of the drug development process, and the data derived is used to help select dosage for preclinical and clinical studies.

KRISHGEN BIOSYSTEMS offers Pharmacokinetics (PK) ELISA Kits for the quantitation of serum protein drug levels to provide accurate pharmacokinetic (PK) data that will help optimize drug dosing regimens.

Key Features of our Assays include:


The use of specific idiotypic antibodies that ensure a higher degree of specificity and sensitivity

The kits are calibrated against innovator drugs to ensure a high degree of accuracy

96 well plates, break apart strips includes calibrator set ready to use components

We offer the world’s largest range of assays for Biologics and other Therapeutic Drugs –

Rituximab (RITUXAN) ELISA | Infliximab (REMICADE) ELISA

Alemtuzumab (LEMTRADA) ELISA | Etarnacept (ENBREL) ELISA

Ustekinumab (STELARA) ELISA | Adalimumab (HUMIRA) ELISA

Bevacizumab (AVASTIN) ELISA | Trastuzumab (HERCEPTIN) ELISA

Humanized Anti-Her2/neu (Herceptin/Trastuzumab) ELISA | Cetuximab (ERBITUX) ELISA

Golimumab (SIMPONI) ELISA | Natalizumab (TYSABRI) ELISA

Omalizumab (XOLAIR) ELISA | Tocilizumab (ACTEMRA) ELISA

Eculizumab (SOLIRIS) ELISA | Ipilimumab (YERVOY) ELISA

Denosumab (PROLIA) ELISA | Atezolizumab (TECENTRIQ) ELISA

Daratumumab (DARZALEX) ELISA | Ranibizumab (LUCENTIS) ELISA

Infliximab (REMICADE) ELISA (measures total drug - free, bound or partially bound) | Etarnacept (ENBREL) ELISA (measures total drug - free, bound or partially bound)

Adalimumab ELISA - Antigen Capture (measures specifically the bound drug complex) | Trastuzumab (HERCEPTIN) ELISA (measures specifically the bound drug complex)

Cetuximab (ERBITUX) ELISA (measures free and partially bound drug) | Golimumab (SIMPONI) ELISA (measures total drug - free, bound or partially bound)

Golimumab (SIMPONI) ELISA (measures specifically the bound drug complex) | Omalizumab (XOLAIR) IgE ELISA (measures specifically the bound drug complex)

Tocilizumab (ACTEMRA) ELISA (measures total drug - free, bound or partially bound) | Ipilimumab (YERVOY) ELISA (measures specifically the bound drug complex)

Denosumab (PROLIA) ELISA (measures free and partially bound drug) | Ranibizumab (LUCENTIS) ELISA (measures total drug - free, bound or partially bound)

Ranibizumab (LUCENTIS) ELISA (measures specifically the bound drug complex) | Daratumumab (DARZALEX) ELISA

Certolizumab pegol (CIMZIA) Inhibition ELISA | Abciximab (REOPRO) ELISA

Abelacimab ELISA | Abituzumab ELISA

Abrezekimab ELISA | Abrilumab ELISA

Afasevikumab ELISA | Alirocumab ELISA

Amatuximab ELISA | Amivantamab ELISA

Andecaliximab ELISA | Anetumab Ravtansine ELISA

Anifrolumab ELISA | Anrukinzumab ELISA

Apamistamab ELISA | Aprutumab ELISA

Aprutumab Ixadotin ELISA | Ascrinvacumab ELISA

Astegolimab ELISA | Atinumab ELISA

Avdoralimab ELISA | Avelumab ELISA

Avizakimab ELISA | Axatilimab ELISA

Azintuxizumab ELISA | Azintuxizumab Vedotin ELISA

Balstilimab ELISA | Basiliximab ELISA

Batoclimab ELISA | Bavituximab ELISA

Begelomab ELISA | Belantamab ELISA

| Belimumab ELISA

| Benralizumab ELISA

Benufutamab ELISA | Bermekimab ELISA

| Besilesomab ELISA

Bimagrumab ELISA | Bimekizumab ELISA

Birtamimab ELISA | Bivatuzumab ELISA

Bleselumab ELISA | Blinatumomab (BLINCYTO) ELISA

Blosozumab ELISA | Brazikumab ELISA

Briakinumab ELISA | Brodalumab (SILIQ) ELISA

Brolucizumab (BEOVU) ELISA | Budigalimab ELISA

Burosumab (CRYSVITA) ELISA | Cabiralizumab ELISA

Camidanlumab Tesirine ELISA | Campath-9H ELISA

Camrelizumab ELISA | Canakinumab (ILARIS) ELISA

Caplacizumab (CABLIVI) ELISA | Carotuximab ELISA

Catumaxomab (REMOVAB) ELISA | Cemiplimab (LIBTAYO) ELISA

Cendakimab ELISA | Cergutuzumab Amunaleukin ELISA

Cetrelimab ELISA | Cibisatamab ELISA

Cinpanemab ELISA | Citatuzumab Bogatox ELISA

| Clazakizumab ELISA

Clivatuzumab Tetraxetan ELISA | Cobolimab ELISA

Codrituzumab ELISA | Cofetuzumab Pelidotin ELISA

Concizumab ELISA | Cosibelimab ELISA

Crenezumab ELISA | Crizanlizumab (ADAKVEO) ELISA

    Total 363 products.





    Join KRISHGEN as a verified distributor to get access to over 1 million sku’s, including reagents, biochemicals and assays. Your one stop vendor for life sciences.

    Subscribe Newsletter


    Krishgen Support